shortagewatch

Home / Blood / Fibrinogen, Human

ATC B02BB01 · Antihemorrhagics

Fibrinogen, Human shortage

As of 31 Oct 2026, Fibrinogen, Human has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 8 products.

Countries4/5
Products8packs or presentations
Short since1 May 20197.5 years ago
Earliest return31 Dec 2026company estimate
No return date0products
Main reasonManufacturing problem
Germany1 pack shortItaly2 packs shortSpain2 packs shortAustriaNo reported shortageBelgium3 packs short

Timeline

GermanyItalySpainBelgium
20222023202420252026FibCLOTFibCLOTFIBRICLOTTEFIBRICLOTTEFIBRYGAFIBRYGAFIBCLOT 1,5 G POLVO Y DISOLVENTE PARA SOLUCIFIBCLOT 1,5 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial (polvo) + 1 vial de disolvente + equipo de transferenciaFIBRYGA 1 G POLVO Y DISOLVENTE PARA SOLUCIONFIBRYGA 1 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial (polvo) + 1 vial de disolvente + 1 Dispositivo de transferencia + 1 FiltroFibclot 1.5 g inj./inf. sol. (pwdr. + solv.)Fibclot 1.5 g inj./inf. sol. (pwdr. + solv.) i.v. vial 1.5 g + 100 mlFibryga 1 g inj./inf. sol. (pwdr. + solv.) iFibryga 1 g inj./inf. sol. (pwdr. + solv.) i.v. vial 1 g + 50 mlRiastap 1 g inj./inf. sol. (pwdr.) i.v. vialRiastap 1 g inj./inf. sol. (pwdr.) i.v. vial 1 gtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEFibCLOTLaboratoire Francais du Fractionnement et des Biotechnologies1 May 201931 Jan 2027Manufacturing problem
Unzureichende Produktionskapazitäten
ITFIBRICLOTTELABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES3 Nov 20251 Mar 2027Manufacturing problem
Problemi produttivi
ITFIBRYGAOCTAPHARMA (IP) SPRL1 Apr 202631 Dec 2026Increased demand
Elevata richiesta: distribuzione contingentata
ESFIBCLOT 1,5 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial (polvo) + 1 vial de disolvente + equipo de transferenciaLaboratoire Francais Du Fractionnement Et Des Biotechnologies7 Jun 202630 Mar 2027Not stated
ESFIBRYGA 1 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial (polvo) + 1 vial de disolvente + 1 Dispositivo de transferencia + 1 FiltroOctapharma S.A.21 Jul 202631 Dec 2026Not stated
BEFibclot 1.5 g inj./inf. sol. (pwdr. + solv.) i.v. vial 1.5 g + 100 mlLaboratoire français du Fractionnement et des Biotechnologies9 Oct 202531 Mar 2027Manufacturing problem
Delay in production
BEFibryga 1 g inj./inf. sol. (pwdr. + solv.) i.v. vial 1 g + 50 ml limitedOctapharma Benelux6 May 202631 Jan 2027Other
Other reason
BERiastap 1 g inj./inf. sol. (pwdr.) i.v. vial 1 g limitedCSL Behring6 May 202631 Jan 2027Other
Other reason

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.